EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of the active parts of Yangxin Tongmai Formula on myocardial injury and spatial metabolic remodeling in rats with myocardial ischemia-reperfusion injury

Di Ye, Yi Wang, Ziyuan Zhao, Caiyue Lin, Wenhua Xu, Jinghui Zheng

Frontiers in Cardiovascular Medicine · 20.07.2026 · 13

DOI: 10.3389/fcvm.2026.1857561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.07.2026. Verfasst von Di Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Guangxi University of Chinese Medicine, Nanning, China. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the protective effects of the active parts of Yangxin Tongmai Formula (apr-YTF) against myocardial ischemia-reperfusion injury (MIRI) in rats from the perspective of spatial metabolic remodeling.

Methods

A rat model of MIRI with blood stasis syndrome was established. Rats were randomized into Control, Model, Vehicle, and apr-YTF groups. apr-YTF was administered by gavage for 14 days. Cardiac function and myocardial injury were assessed by echocardiography, serum myocardial enzyme assays, triphenyltetrazolium chloride (TTC) staining, and hematoxylin and eosin (HE) staining. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) was used to analyze the spatial distribution patterns and metabolic profiles of differential metabolites in myocardial tissue. Results apr-YTF significantly improved left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS), reduced serum creatine kinase (CK), creatine kinase-MB isoenzyme (CK-MB), lactate dehydrogenase (LDH), and lactate dehydrogenase 1 (LDH1) levels, decreased infarct size, and alleviated myocardial fibrosis and inflammatory infiltration. MALDI-MSI identified 1,282 metabolites, including 702 MIRI model-associated differential metabolic features, mainly including amino acids, nucleotides, and glycerophospholipids. The MIRI group exhibited extensive metabolic remodeling involving lipid, amino acid, nucleotide metabolism, and cofactor biosynthesis pathways. After apr-YTF intervention, 17 reversed differential metabolic features showed recovery trends.

Conclusion

The active parts of Yangxin Tongmai Formula ameliorated myocardial injury and were associated with partial correction of spatial metabolic remodeling in rats with MIRI.

Schlagwörter

Stichwörter der Autor:innen

MALDI-MSIactive parts of Yangxin Tongmai Formulablood stasis syndromemyocardial ischemia-reperfusion injuryspatial metabolic remodeling

Autor:innen und Institutionen

  • Graduate School, Guangxi University of Chinese Medicine, Nanning, China.
  • Academic Affairs Office, Guangxi University of Chinese Medicine, Nanning, China.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Ye, D., Wang, Y., Zhao, Z., Lin, C., Xu, W., & Zheng, J. (2026). Effects of the active parts of Yangxin Tongmai Formula on myocardial injury and spatial metabolic remodeling in rats with myocardial ischemia-reperfusion injury. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1857561

Vancouver

Ye D, Wang Y, Zhao Z, Lin C, Xu W, Zheng J. Effects of the active parts of Yangxin Tongmai Formula on myocardial injury and spatial metabolic remodeling in rats with myocardial ischemia-reperfusion injury. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1857561

BibTeX
@article{Ye2026,
  author = {Ye, Di and Wang, Yi and Zhao, Ziyuan and Lin, Caiyue and Xu, Wenhua and Zheng, Jinghui},
  title = {Effects of the active parts of Yangxin Tongmai Formula on myocardial injury and spatial metabolic remodeling in rats with myocardial ischemia-reperfusion injury},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1857561}
}
Kostenlos starten →